Diagnostic and therapeutic approaches to multiple myeloma patients: ‘Real-world’ data from representative multicentre treatment surveys in Germany between 2008 and 2011

Por Moehler, Thomas M., Merz, Maximilian, Kellermann, Lenka, Goldschmidt, Hartmut, Knauf, Wolfgang
Publicado no Oncol Lett (2016)

The Glycome of Normal and Malignant Plasma Cells

Por Moehler, Thomas M., Seckinger, Anja, Hose, Dirk, Andrulis, Mindaugas, Moreaux, Jèrôme, Hielscher, Thomas, Willhauck-Fleckenstein, Martina, Merling, Anette, Bertsch, Uta, Jauch, Anna, Goldschmidt, Hartmut, Klein, Bernard, Schwartz-Albiez, Reinhard
Publicado em 2013

Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

Por Auel, Britta, Goldschmidt, Hartmut, Geer, Thomas, Moehler, Thomas M., Platzbecker, Uwe, Naumann, Ralph, Blau, Igor, Hänel, Mathias, Knauf, Wolfgang, Nückel, Holger, Salwender, Hans-Jürgen, Scheid, Christof, Weisel, Katja, Gorschlüter, Marcus, Glasmacher, Axel, Schmidt-Wolf, Ingo G. H.
Publicado em 2011

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

Por Kropff, Martin, Baylon, Honorata Giongco, Hillengass, Jens, Robak, Tadeusz, Hajek, Roman, Liebisch, Peter, Goranov, Stefan, Hulin, Cyrille, Bladé, Joan, Caravita, Tommaso, Avet-Loiseau, Herve, Moehler, Thomas M., Pattou, Claire, Lucy, Lela, Kueenburg, Elisabeth, Glasmacher, Axel, Zerbib, Robert, Facon, Thierry
Publicado em 2012